Sentence examples for block of therapy from inspiring English sources

Consistent with international consensus statement recommendations, all participating children will receive a block of therapy treatment commencing within two weeks following BoNT-A or sham [ 19, 61].

Re-emerging lines (herein labeled 'R') were thus harvested after either one block of therapy ('VXLD') or repeated chemotherapy blocks ('VXLD2'), respectively.

With a longer block of therapy, we may expect more robust changes and/or involvement of additional regions, particularly those known to support oral-motor control and expressive language (i.e., Rolandic and inferior frontal cortex).

Within these training programs, the practitioners learn the therapies' techniques, the building blocks of therapy application.

At the time these assays were performed, 390 patients, recruited from participating centres in UK, Netherlands, Australia and New Zealand, had completed the first three blocks of therapy containing ASNase (Supplementary Figure 1).

Here, we report our experience of dose dense weekly carboplatin AUC 3 and paclitaxel 70 mg m−2 on day 1, 8, 15 q 4 weekly administered in patients with heavily pre-treated platinum-refractory and/or platinum-resistant ovarian cancer delivered for an intended six blocks of therapy (18 cycles).

Results show improvements in the development of speech and cognitive abilities even after the first block of music therapy treatment.

In this study, we investigate possible cortical thickness correlates of idiopathic apraxia of speech in childhood, and changes associated with participation in an 8-week block of PROMPT therapy.

Missing values were imputed using the method of last observation carried forward with the following rules: a missing value before a block of music therapy or no treatment was replaced with the corresponding pre-session value.

Phonological memory (PGN) indicated statistically significant results during the first waiting period (T1-T2 p = 0,008) and also after the second block of music therapy (T2-T3 p = 0,001; see Table 1).

[ 73] The question is how best to combine IL-1 blocking agents with either anti-VEGF or anti-VEGF receptors or kinase inhibitors.The best trial design option is to add IL-1 blocking therapies to standards of therapy.